These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24801038)

  • 1. [Tumor hypoxia: a key player in the regulation of stromal and anti-tumor responses].
    Hasmim M; Messai Y; Noman MZ; Chouaib S
    Med Sci (Paris); 2014 Apr; 30(4):422-8. PubMed ID: 24801038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response regulation in the tumor microenvironment by hypoxia.
    Labiano S; Palazon A; Melero I
    Semin Oncol; 2015 Jun; 42(3):378-86. PubMed ID: 25965356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression.
    Fallone F; Britton S; Nieto L; Salles B; Muller C
    Oncogene; 2013 Sep; 32(37):4387-96. PubMed ID: 23085754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eicosanoids and other lipid mediators and the tumor hypoxic microenvironment.
    Krishnamoorthy S; Honn KV
    Cancer Metastasis Rev; 2011 Dec; 30(3-4):613-8. PubMed ID: 22042480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and lymphangiogenesis in tumor microenvironment and metastasis.
    Ji RC
    Cancer Lett; 2014 Apr; 346(1):6-16. PubMed ID: 24333723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments.
    Li W; Sun X
    Recent Pat Anticancer Drug Discov; 2018; 13(4):455-468. PubMed ID: 30173649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies.
    Magagnin MG; Koritzinsky M; Wouters BG
    Drug Resist Updat; 2006; 9(4-5):185-97. PubMed ID: 16926105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Can tumor hypoxia be turned into a chemotherapeutic advantage?].
    Trédan O; Grantab R; Dumontet C
    Bull Cancer; 2008 May; 95(5):528-34. PubMed ID: 18541517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathways: hypoxia response in immune cells fighting or promoting cancer.
    Palazón A; Aragonés J; Morales-Kastresana A; de Landázuri MO; Melero I
    Clin Cancer Res; 2012 Mar; 18(5):1207-13. PubMed ID: 22205687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers.
    Shi M; Guo XT; Shu MG; Chen FL; Li LW
    Med Hypotheses; 2007; 69(1):33-5. PubMed ID: 17280792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
    Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
    Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH control mechanisms of tumor survival and growth.
    Parks SK; Chiche J; Pouyssegur J
    J Cell Physiol; 2011 Feb; 226(2):299-308. PubMed ID: 20857482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NADPH oxidase subunit 4 mediates cycling hypoxia-promoted radiation resistance in glioblastoma multiforme.
    Hsieh CH; Wu CP; Lee HT; Liang JA; Yu CY; Lin YJ
    Free Radic Biol Med; 2012 Aug; 53(4):649-58. PubMed ID: 22713363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypoxic microenvironment and cancer dormancy].
    Okuyama H; Inoue M
    Gan To Kagaku Ryoho; 2011 Oct; 38(10):1559-64. PubMed ID: 21996947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy.
    Meijer TW; Kaanders JH; Span PN; Bussink J
    Clin Cancer Res; 2012 Oct; 18(20):5585-94. PubMed ID: 23071360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics.
    Lin Q; Yun Z
    Cancer Biol Ther; 2010 Jun; 9(12):949-56. PubMed ID: 20581454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels.
    Parks SK; Mazure NM; Counillon L; Pouysségur J
    J Cell Physiol; 2013 Sep; 228(9):1854-62. PubMed ID: 23459996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Hypoxia: A Key Determinant of Microenvironment Hostility and a Major Checkpoint during the Antitumor Response.
    Francis A; Venkatesh GH; Zaarour RF; Zeinelabdin NA; Nawafleh HH; Prasad P; Buart S; Terry S; Chouaib S
    Crit Rev Immunol; 2018; 38(6):505-524. PubMed ID: 31002604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.